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We report the unusual occurrence of a cellular angiofibroma in prostatic tissue. In this case, a 84-year-old man presented in the
emergency room with urinary retention. Ultrasound revealed an enlarged prostate, which was suggestive for benign prostatic
hyperplasia. The patient was treated with a Millin retropubic prostatectomy. Macroscopically the prostate contained multiple
circumscribed nodules. Microscopic examination of the tumor showed the appearance of cellular angiofibroma, consisting of bland
spindle cells and prominent, hyalinized vessels.The diagnosis was supported by FISH, which revealedmonoallelic loss of RB1/13q14
region, as seen in spindle cell lipoma, (extra-) mammary myofibroblastoma, and cellular angiofibroma. Cellular angiofibromas are
rare, benign soft tissue tumours and were never reported in the prostatic gland.
1. Introduction
Cellular angiofibroma (CAF) is a rare benign mesenchymal
lesion that was first described in 1997 by Nucci et al. [1]
as a distinct mesenchymal neoplasm composed of 2 major
components: spindle cells and prominent vessels. This orig-
inal report presented four cases, all occurring in the vulvar
region of middle aged woman. Since then, similar lesions
have been described in the inguinoscrotal region of men,
originally labeled as “angiomyofibroblastoma-like tumor of
the male genital tract” [1, 2]. Different case reports reveal
similar lesions in other sites: subcutaneous tissue of the
chest wall [3], male pelvis [4], and oral mucosa [5], but an
intraprostatic location was hitherto unreported.
2. Case Report
An 84-year-old man presented in the emergency room with
urinary retention. Ultrasound revealed an enlarged prostate,
suggestive for benign prostatic hyperplasia. The patient was
treated with a Millin retropubic prostatectomy. Macroscopi-
cal examination showed prostatic tissue with firm to rubbery,
white, circumscribed nodules.
Microscopic examination revealed a well-delineated
nodular lesion with normal surrounding prostatic tissue
(Figure 3). The lesion consisted of loosely arranged, bland
spindle cells in a myxoid to collagenous stroma (Figure 1).
Prominent vessels were present with marked hyalinization
of the wall in some of them (Figure 2). Mitotic figures were
absent. Morphologically, these features were suggestive for
CAF.
Immunohistochemical analysis revealed strong positivity
for alfa-sma, desmin, caldesmon, CD34, and progesteron
receptor (PR) (Figure 4). CD31, ALK1, Myogenin, and estro-
gen receptor (ER) were negative.
Interphase dual-colour fluorescence in situ hybridization
(FISH) was performed on 4𝜇m formalin-fixed, paraffin
embedded tumour sections, by a cohybridization of Spec-
trum Orange-labelled RB1/13q14 probe (LSI RB1-SO; Vysis
Inc., Downers Grove, IL, USA) and a reference Spectrum
Green-labelled chromosome X centromere probe (CEPX-
SG, Vysis Inc.), as previously described [6]. The number
of differentially labeled hybridization signals representing
investigated gene and reference centromere X chromosomal
regions were individually recorded for 100 nonoverlapped
interphase nuclei, using a Zeissmicroscope (Axioplan 2, Jena,
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Figure 1: Low power view, showing the cellular spindle cell
component and the hyaline vessels.
Figure 2: Detail of the blood vessels with hyalinized wall.
Germany) equipped with the appropriate filters and CYTO-
VISION software. A cut-off of 30% was established for a
positive result.
By FISH, 48% of nuclei demonstrated the monoallelic
RB1/13q14 loci loss (Figure 5), as indicated by the presence
of only one red signal in reference to chromosome X probe
(green signal).
3. Discussion
Nonepithelial prostatic lesions are infrequent and cover a
broad spectrum of benign and highly aggressive tumors.
CAFs are benign mesenchymal tumors, which occur
equally in adult women and men [7]. Most often they occur
in the vulvovaginal and inguinoscrotal region, but they are
reported in other sites, including oral mucosa, male pelvis,
and subcutaneous tissue of the chest wall [3–5]. In women
they tend to occur earlier,most often in the fifth decade, while
men are mostly affected in the seventh decade [7].The tumor
size in female patients is often smaller (median 2.8 cm) than
that in male patients (median 7 cm) [7].
Ultrasound is often the initial imaging examination and
reveals a well circumscribed, nodular lesion. To differentiate
the lesion, MRI can be useful. MRI features of CAF are con-
sistent with the pathological characteristics: a well circum-
scribed, benign cellular, and fibrous tumor with prominent
vascularity [8].
Figure 3: Prostatic tissue next to CAF.
Macroscopical examination of those lesionsmostly reveal
one or multiple nodules which are firm to rubbery in
consistency and white, pale, or grey in color [9].
Immunohistological analysis reveals CD34 expression
in approximately 66% of cases, together with alfa-sma and
desmin positivity in a minority of tumors. They show posi-
tivity for ER and PR in 35–55%.
On morphology, inflammatory myofibroblastic tumor,
solitary fibrous tumor, and cellular angiofibroma can mimic
each other.
Solitary fibrous tumors (SFT) are mesenchymal lesions,
which are also characterized by bland spindle cells, promi-
nent blood vessels, with a typically branching “staghorn” pat-
tern andhyalinization of the stroma. LikeCAF, they also show
CD34 positivity, but desmin expression is not a feature of
SFT. Recently, nuclear STAT6 expression has been reported to
be characteristic for SFT [10]. The differential diagnosis with
stroma-predominant benign prostatic hyperplasia (BPH) and
stromal tumor of uncertain malignant potential (STUMP)
also has to be made.
STUMPS are tumors of specialized prostatic stroma in
which definitive features of sarcoma are not identified. The
tumor is often solitary and the proliferative stroma may
infiltrate between benign glands. Mitotic activity is rare to
absent. Necrosis is also absent. Four histological patterns are
described: degenerative atypia, hypercellular stroma,myxoid,
and phyllodes-type growth [11]. Only the last one shows a
biphasic stromal and epithelial proliferation. The first three
are purely mesenchymal proliferations. Cytological atypia is
variable but more prominent in the first pattern. Immunohis-
tochemically, STUMP expresses CD34 and muscle markers
such as desmin and smoothmuscle actin (SMA), like CAFdo.
They also can express progesteron receptor (PR). However,
STUMP lacks the prominence of blood vessels, as described
in CAF.
Benign prostatic hyperplasia typically has a multinodular
growth and mostly arises from the transition zone (TZ).
There is hyperplasia of both glandular and stromal tissues
with papillary buds, infoldings, and cysts.
In benign prostatic hyperplasia abundant stromal capil-
laries are described with stromal cell condensation around
the vessels. Fibromyxoid nodules can be seen within the
lesion.
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Figure 4: Positivity for PR (a), CD34 (b), and desmin (c).
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Figure 5: Double-colour FISH analysis of the tumour: loss of chromosome RB1/13q14 region as indicated by the presence of single red signals
from Spectrum-Orange labelled RB1 locus specific probe in reference to single green signals from Spectrum-Green labelled CEPX probe
(short arrows). Representative tumour area under lower (a) and higher magnification (b). Long arrows on image (b) point to macrophages
that show diploid RB1 copy number, as expected in normal cells (internal control).
Inflammatory myofibroblastic tumor of the bladder is
a well-recognized entity; however, prostatic inflammatory
myofibroblastic tumor is extremely rare. Histologically, this
tumor exhibits proliferation of uniform, bland spindle
(myofibroblastic) cells of variable cellularity in a loose
myxoid stroma. It often contains granulation tissue-type
vascularity and a prominent inflammatory cell infiltrate.
Immunohistochemically, these tumors coexpress alfa-sma,
desmin, broad spectrum keratins, and low molecular weight
keratins, but not CD34. ALK1 rearrangement and expression
occurs in 20–75% of IMFs [11].
Genetic testing by FISH revealed a loss of RB1 (13q14-) in
our tumor, which is described in spindle cell lipoma, (extra-)
mammary myofibroblastoma, and cellular angiofibroma [7,
12, 13]. These entities also show morphologic overlap, but
also subtle distinct features. The main features of cellular
angiofibroma are the cellular spindle cell component and
the presence of prominent, hyalinized blood vessels and
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minimal adipose tissue. The thick blood vessels are not
seen in the other two entities. Spindle cell lipomas show a
mixture of mature adipocytes and bland spindle cells in a
mucinous, myxoid, or fibrous background. The spindle cells
are arranged in short fascicles and associated with thick, ropy
collagen bundles. In (extra-) mammary myofibroblastoma,
fascicles of spindle cells having features of myofibroblasts
are seen, with intervening hyalinized collagenous stroma
and a variably prominent component of adipose tissue. This
finding suggests that these tumors arise from a common
stroma precursor cell, which undergoes (myo)fibroblastic or
adipocyte differentiation [6].
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